UNSPSC 85811923: Introduction of oxazolidinones into ear, via natural or artificial opening

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of oxazolidinones into ear, via natural or artificial opening. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0B728

UNSPSC 85811923, Introduction of oxazolidinones into ear, via natural or artificial opening, is a Commodity code with negligible state and local procurement relevance. The code nominally describes pharmaceutical administration routes for otic antimicrobial agents, yet the recent opportunities tagged under it bear no connection to this scope and instead reflect diverse health service procurements unrelated to oxazolidinone pharmaceuticals—virtual urgent care, occupational health screening, cancer registry services, retinal imaging devices, EMS staffing, employee wellness platforms, opioid use disorder treatment programs, and nursing home operations.

No state and local government opportunities in the most recent dataset actually solicit oxazolidinone products or ear-focused pharmaceutical services matching the code's definition. The tagging appears to reflect a classification error in the underlying procurement systems rather than legitimate activity within this commodity. Unless your firm specializes in niche pharmaceutical distribution or medical supply logistics and has relationships with state health authorities managing inpatient or outpatient pharmacy inventories, this code does not represent a viable pursuit vector for state and local business development at this time.